NO20055922L - Farmasoytiske anvendbare salter av karboksylsyrderivater - Google Patents
Farmasoytiske anvendbare salter av karboksylsyrderivaterInfo
- Publication number
- NO20055922L NO20055922L NO20055922A NO20055922A NO20055922L NO 20055922 L NO20055922 L NO 20055922L NO 20055922 A NO20055922 A NO 20055922A NO 20055922 A NO20055922 A NO 20055922A NO 20055922 L NO20055922 L NO 20055922L
- Authority
- NO
- Norway
- Prior art keywords
- oxoethoxy
- phenylethyl
- ethoxy
- hexyl
- phenyl
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- VFYAWARECOZRBD-VWLOTQADSA-N (2s)-2-ethoxy-3-[4-[2-[hexyl(2-phenylethyl)amino]-2-oxoethoxy]phenyl]propanoic acid Chemical compound C=1C=C(C[C@H](OCC)C(O)=O)C=CC=1OCC(=O)N(CCCCCC)CCC1=CC=CC=C1 VFYAWARECOZRBD-VWLOTQADSA-N 0.000 abstract 8
- LOPKSXMQWBYUOI-DTWKUNHWSA-N (1r,2s)-1-amino-2,3-dihydro-1h-inden-2-ol Chemical class C1=CC=C2[C@@H](N)[C@@H](O)CC2=C1 LOPKSXMQWBYUOI-DTWKUNHWSA-N 0.000 abstract 1
- 239000004381 Choline salt Substances 0.000 abstract 1
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 abstract 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical class C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical class C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 abstract 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical class C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 abstract 1
- 235000019417 choline salt Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003248 quinolines Chemical class 0.000 abstract 1
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical class CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314129.8A GB0314129D0 (en) | 2003-06-18 | 2003-06-18 | Therapeutic agents |
| PCT/SE2004/000964 WO2004110984A1 (en) | 2003-06-18 | 2004-06-16 | Pharmaceutically useful salts of carboxylic acid derivates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055922L true NO20055922L (no) | 2006-01-06 |
Family
ID=27636788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055922A NO20055922L (no) | 2003-06-18 | 2005-12-13 | Farmasoytiske anvendbare salter av karboksylsyrderivater |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20060142389A1 (pt) |
| EP (1) | EP1638922A1 (pt) |
| JP (1) | JP3822900B1 (pt) |
| KR (1) | KR20060027348A (pt) |
| CN (1) | CN1809529A (pt) |
| AR (1) | AR044801A1 (pt) |
| AU (1) | AU2004247610B2 (pt) |
| BR (1) | BRPI0411525A (pt) |
| CA (1) | CA2528932A1 (pt) |
| CO (1) | CO5650228A2 (pt) |
| GB (1) | GB0314129D0 (pt) |
| IL (1) | IL172167A0 (pt) |
| IS (1) | IS8231A (pt) |
| MX (1) | MXPA05013714A (pt) |
| MY (1) | MY137277A (pt) |
| NO (1) | NO20055922L (pt) |
| RU (1) | RU2005138590A (pt) |
| SA (1) | SA04250169B1 (pt) |
| TW (1) | TW200503677A (pt) |
| UA (1) | UA81807C2 (pt) |
| UY (1) | UY28375A1 (pt) |
| WO (1) | WO2004110984A1 (pt) |
| ZA (1) | ZA200510252B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104334D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| GB0314079D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0229931D0 (en) * | 2002-12-21 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| BR0311932A (pt) | 2002-06-20 | 2005-03-22 | Astrazeneca Ab | Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado |
| SE0403072D0 (sv) * | 2004-12-16 | 2004-12-16 | Astrazeneca Ab | Pharmaceutically useful salts of carboxylic acid derivates |
| WO2007004957A1 (en) * | 2005-07-05 | 2007-01-11 | Astrazeneca Ab | Novel crystalline form |
| AR055073A1 (es) * | 2005-07-11 | 2007-08-01 | Astrazeneca Ab | Agentes terapeuticos |
| NO2686520T3 (pt) | 2011-06-06 | 2018-03-17 | ||
| WO2012170439A1 (en) | 2011-06-06 | 2012-12-13 | The Ohio State University | Methods for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer |
| JP2016521747A (ja) | 2013-06-13 | 2016-07-25 | アケビア セラピューティクス インコーポレイテッドＡｋｅｂｉａ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | 貧血治療のための組成物及び方法 |
| MY180626A (en) | 2013-11-15 | 2020-12-03 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
| US10150734B2 (en) | 2015-01-23 | 2018-12-11 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| US11324734B2 (en) | 2015-04-01 | 2022-05-10 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
| WO2021117767A1 (ja) | 2019-12-10 | 2021-06-17 | 田辺三菱製薬株式会社 | 含窒素ヘテロアリールカルボキサミド酢酸誘導体の製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2219172C2 (ru) * | 1999-04-06 | 2003-12-20 | Санкио Компани, Лимитед | α-ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ КАРБОНОВЫХ КИСЛОТ |
| SE0104334D0 (sv) * | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-18 GB GBGB0314129.8A patent/GB0314129D0/en not_active Ceased
-
2004
- 2004-06-09 TW TW093116585A patent/TW200503677A/zh unknown
- 2004-06-16 UA UAA200511381A patent/UA81807C2/uk unknown
- 2004-06-16 US US10/560,657 patent/US20060142389A1/en not_active Abandoned
- 2004-06-16 AU AU2004247610A patent/AU2004247610B2/en not_active Expired - Fee Related
- 2004-06-16 MX MXPA05013714A patent/MXPA05013714A/es not_active Application Discontinuation
- 2004-06-16 EP EP04749009A patent/EP1638922A1/en not_active Withdrawn
- 2004-06-16 MY MYPI20042310A patent/MY137277A/en unknown
- 2004-06-16 SA SA04250169A patent/SA04250169B1/ar unknown
- 2004-06-16 CN CNA2004800169480A patent/CN1809529A/zh active Pending
- 2004-06-16 CA CA002528932A patent/CA2528932A1/en not_active Abandoned
- 2004-06-16 BR BRPI0411525-2A patent/BRPI0411525A/pt not_active IP Right Cessation
- 2004-06-16 WO PCT/SE2004/000964 patent/WO2004110984A1/en not_active Ceased
- 2004-06-16 KR KR1020057024204A patent/KR20060027348A/ko not_active Withdrawn
- 2004-06-16 JP JP2006517039A patent/JP3822900B1/ja not_active Expired - Fee Related
- 2004-06-16 RU RU2005138590/04A patent/RU2005138590A/ru not_active Application Discontinuation
- 2004-06-17 AR ARP040102111A patent/AR044801A1/es not_active Application Discontinuation
- 2004-06-18 UY UY28375A patent/UY28375A1/es not_active Application Discontinuation
-
2005
- 2005-11-24 IL IL172167A patent/IL172167A0/en unknown
- 2005-12-13 NO NO20055922A patent/NO20055922L/no not_active Application Discontinuation
- 2005-12-15 ZA ZA200510252A patent/ZA200510252B/en unknown
- 2005-12-22 CO CO05129035A patent/CO5650228A2/es not_active Application Discontinuation
-
2006
- 2006-01-13 IS IS8231A patent/IS8231A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2005138590A (ru) | 2006-07-27 |
| IS8231A (is) | 2006-01-13 |
| BRPI0411525A (pt) | 2006-08-01 |
| SA04250169A (ar) | 2005-12-03 |
| CO5650228A2 (es) | 2006-06-30 |
| MY137277A (en) | 2009-01-30 |
| AU2004247610A1 (en) | 2004-12-23 |
| IL172167A0 (en) | 2009-02-11 |
| ZA200510252B (en) | 2006-12-27 |
| GB0314129D0 (en) | 2003-07-23 |
| SA04250169B1 (ar) | 2007-08-07 |
| UY28375A1 (es) | 2005-01-31 |
| EP1638922A1 (en) | 2006-03-29 |
| MXPA05013714A (es) | 2006-06-27 |
| JP2006527766A (ja) | 2006-12-07 |
| KR20060027348A (ko) | 2006-03-27 |
| JP3822900B1 (ja) | 2006-09-20 |
| UA81807C2 (uk) | 2008-02-11 |
| CA2528932A1 (en) | 2004-12-23 |
| TW200503677A (en) | 2005-02-01 |
| CN1809529A (zh) | 2006-07-26 |
| AU2004247610B2 (en) | 2008-04-17 |
| US20060142389A1 (en) | 2006-06-29 |
| AR044801A1 (es) | 2005-10-05 |
| WO2004110984A1 (en) | 2004-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055922L (no) | Farmasoytiske anvendbare salter av karboksylsyrderivater | |
| MA29416B1 (fr) | Inhibiteurs d'age | |
| JO3142B1 (ar) | طريقة تحضير 5-ثنائي فينيل -4-أمينو-2-ميثيل بينتانويك أسيد | |
| CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| DE602004024545D1 (de) | Indungen | |
| NO20073755L (no) | Ibandronatpolymorf B | |
| CY1116498T1 (el) | Διεργασια για την παρασκευη (r)-(-)-3-(καρβαμοϋλομεθυλ)-5-μεθυλεξανοϊκου οξεος και πρεγκαμπαλινης και συνθεση ενδιαμεσων | |
| CR10206A (es) | Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
| CY1112185T1 (el) | Σταθερο συμπλοκο δραστικων ουσιων απο αλατα των o-ακετυλοσαλικυλικων οξεων με βασικα αμινοξεα και γλυκινη | |
| EA201001671A1 (ru) | Способ стереоселективного ферментативного гидролиза эфира 5-метил-3-нитрометилгексановой кислоты | |
| BRPI0409105A (pt) | análogos de quinobenzoxazina substituìdos | |
| EA200400994A1 (ru) | Новые 1,2,3-замещенные производные индолизина, являющиеся ингибиторами факторов роста фибробластов, способ их получения и фармацевтические композиции, содержащие их | |
| BRPI0509982A8 (pt) | cepa isolada de escherichia coli, e, método para produzir um composto | |
| EA200701810A1 (ru) | Производное изоксазолина и новый способ его получения | |
| EA201071424A1 (ru) | Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина | |
| NO20055923L (no) | Farmasoytisk anvendbare salter av karboksylsyrderivater | |
| BR112015000966B1 (pt) | método para a síntese de n-(fosfonometil)glicina ou um de seus derivados selecionados a partir do grupo que consiste em seus sais, seus ésteres de fosfonato e seus sais de éster de fosfonato | |
| CY1112979T1 (el) | Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου | |
| EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
| SE0403072D0 (sv) | Pharmaceutically useful salts of carboxylic acid derivates | |
| HRP20060079B1 (en) | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate | |
| AR044267A1 (es) | Compuesto intermedio util para la preparacion de pioglitazona | |
| TH69682A (th) | สารบำบัด | |
| DK1585728T3 (da) | Iminosyrederivater som inhibitorer af matrix-metalloproteinaser | |
| UY29268A1 (es) | Sales farmaceuticamente aceptables de derivados de acido carboxilico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |